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Abstract
Background: Although cesarean delivery and prenatal exposure to antibiotics are likely to affect the gut microbiome in
infancy, their effect on the development of atopic dermatitis (AD) in infancy is unclear. The influence of individual
genotypes on these relationships is also unclear. To evaluate with a prospective birth cohort study whether cesarean
section, prenatal exposure to antibiotics, and susceptible genotypes act additively to promote the development of AD in
infancy.
Methods: The Cohort for Childhood of Asthma and Allergic Diseases (COCOA) was selected from the general Korean
population. A pediatric allergist assessed 412 infants for the presence of AD at 1 year of age. Their cord blood DNA was
subjected to interleukin (IL)-13 (rs20541) and cluster-of-differentiation (CD)14 (rs2569190) genotype analysis.
Results: The combination of cesarean delivery and prenatal exposure to antibiotics associated significantly and positively
with AD (adjusted odds ratio, 5.70; 95% CI, 1.19–27.3). The association between cesarean delivery and AD was significantly
modified by parental history of allergic diseases or risk-associated IL-13 (rs20541) and CD14 (rs2569190) genotypes. There
was a trend of interaction between IL-13 (rs20541) and delivery mode with respect to the subsequent risk of AD. (P for
interaction = 0.039) Infants who were exposed prenatally to antibiotics and were born by cesarean delivery had a lower total
microbiota diversity in stool samples at 6 months of age than the control group. As the number of these risk factors
increased, the AD risk rose (trend p,0.05).
Conclusion: Cesarean delivery and prenatal antibiotic exposure may affect the gut microbiota, which may in turn influence
the risk of AD in infants. These relationships may be shaped by the genetic predisposition.
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Introduction
Although cesarean delivery and prenatal exposure to antibiotics
are likely to affect the gut microbiome in infancy [1,2], their effect
on the development of atopic dermatitis (AD) in infancy is unclear
[3–6].
Microbes are recognized by the innate immune system using
pattern recognition receptors (PRRs). cluster-of-differentiation
(CD)14 is, together with Toll-like receptor(TLR)4, involve in the
recognition and signal transduction of bacterial endotoxin, a major
component of the bacterial cell wall of gram negative bacteria.
Downstream affects of CD14/TLR receptor activation on antigen
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presenting cells include the release of cytokines, such as IL-10, and
IL-12 [7]. Interleukin (IL)-13 is a cytokine typically produced
during Th2 responses and plays a crucial role in atopy and allergic
diseases [8].
Several studies show that polymorphisms in the immune system-
related genes IL-13 and CD14 associate with AD [9–11].
However, the results from cross-sectional and case-control studies
on the influence of these gene polymorphisms on the development
of AD in different populations are inconsistent [12–14]. They may
reflect differences between the studies in terms of environmental
factors that modify genetic associations.
Early microbial contact (i.e., during fetal life and infancy) has
been suggested to be involved in the initiation and perpetuation of
the aberrant immune activation and responsiveness that plays a
central role in the pathogenesis of allergic diseases. This may be
particularly true for AD, which appears early in life. Individual
immune system-related genotypes may also shape the responsive-
ness to gut microbes during fetal life and infancy.
It was hypothesized that prenatal exposure to antibiotics and
cesarean delivery may affect the gut microbiota in early infancy,
which is an important period in the development of the immune
system. It was also hypothesized that these prenatal risk factors
may be modified by the genetic background. This is the first study
to assess how cesarean section birth, prenatal antibiotic exposure,
and IL-13 and CD14 risk alleles interact in the development of AD
in infancy.
Methods
Ethics Statement
This study was approved by the institutional review board of the
Asan Medical Center (IRB No. 2008-0616), the Samsung Medical
Center (IRB No. 2009-02-021), the Severance Hospital (IRB
No. 4-2008-0588) and the CHA Medical Center (IRB No. 2010-
010). Written informed consent was confirmed by each IRB and
obtained from the parents of each infant.
Study Population
The Cohort for Childhood Origin of Asthma and Allergic
Diseases (COCOA) was composed of the general Korean
population after recruiting healthy pregnant women who delivered
at four hospitals in a metropolitan city (Seoul). The recruitment
period commenced in December 2007. A modified questionnaire
of the International Study of Asthma and Allergies in Childhood
(ISAAC) was completed by the parents at 36 weeks gestational age
[15]. The delivery mode and other prenatal variables were
extracted from the maternal and neonatal medical records shortly
after delivery. The presence of AD was clinically diagnosed by
pediatric allergy specialists using the criteria of Hanifin and Rajka
[16] when the infants were followed up at the hospital at 12
months of age.
Of the 534 12-month infants who were enrolled, 122 infants
dropped out. At the time the present study was conducted, 412 of
the infants met the inclusion criteria: age.1 year, examined for
the presence of AD at 12 months by pediatric allergy specialists,
and completion of the 12 month questionnaire by the parents.
DNA Collection and SNP Genotyping
Genomic DNA was extracted from the cord blood mononuclear
cells of each child and genotyped for the IL-13 rs2569190 and
CD14 rs1927911 polymorphisms by using the TagMan fluoro-
genic 59 nuclease assay (ABI, Foster City, CA, USA). The
endpoint fluorescent readings were performed on an ABI 7900
HT Sequence Detection System (ABI, Foster City, CA, USA).
Duplicate samples and negative controls were included to ensure
genotyping accuracy.
Microbial Analysis
Fecal samples were obtained from 11 of the 412 infants in this
study at the age of 6 months. Of these, six had both prenatal
antibiotic exposure and were delivered by cesarean section, while
the remaining five were delivered vaginally and were not exposed
to antibiotics prenatally. These infants were selected randomly.
The fecal sampling and DNA extraction methods have been
described in detail elsewhere [17].
Statistical Analysis
The means and standard deviations or frequencies and
percentages of general characteristics were presented for overall
study population.
The multivariable logistic regression models were used to
estimate odd ratios (OR) and corresponding 95% confidence
intervals (95% CI) for comparison of AD at infancy occurrence
risk by relevant covariates. The following covariates were
considered as potential confounders: gestational age at birth, sex,
pre-pregnancy maternal body-mass index (BMI), maternal age at
delivery, maternal education level, prenatal exposure to smoke,
prenatal exposure to pets, presence of older siblings, and parental
allergic disease history. The regression models included a priori
potential confounding co-variables which are known risk factors of
infant AD established in the literature, and significant variables
identified from initial univariate analyses (p,0.2). Data from
subjects were divided into 4 groups based on environmental
factors (delivery mode and prenatal exposure to antibiotics) and
genetic background (parental history of allergic diseases and
genotypes) and logistic regression were used to estimate aORs.
Finally, we tested for trends regarding the effect of the number
of risk factors (early life environmental factors and genetic
polymorphisms) on the development of AD in infancy. P-value
for trends was determined using the general linear model for
continuous variables.
All statistical tests were two-sided significance levels of p value
less than 0.05. Statistical analyses were done with IBM SPSS
Statistics 20.0 (IBM SPSS Statistics, Inc., Chicago, IL).
Results
Study Population Characteristics
The study included 412 infants (229 boys and 183 girls) and
their families (Table 1). In total, 9.9% of all infants were exposed
to antibiotics prenatally and 32.5% were born by cesarean
delivery. Moreover, 47.7% of the infants had at least one parent
with a history of allergic diseases and 28.2% were diagnosed with
AD at 12 months of age.
Relationship between AD in Infancy and Delivery Mode
and/or Prenatal Antibiotic Exposure
In multivariable regression analyses, cesarean section increased
the odds or AD in infancy by 1.84 (95% CIs 0.95–3.56; p = 0.07)
and prenatal antibiotic exposure did not increased (data not
shown). The combination of cesarean section and prenatal
antibiotic exposure significantly increased the odds of AD in
infancy (adjusted OR [aOR] 5.70, 95% CIs 1.19–27.3, p = 0.03).
Stool analysis at 6 months of age in 11 randomly selected infants
revealed that the total microbiota of the infants with prenatal
antibiotic exposure and cesarean delivery was less diverse than the
total microbiota of the control infants (Fig. S1).
Gene & Environmental Factors Had a Additive Effect on AD
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Effect of Parental Allergic Disease History, Delivery Mode,
and/or Prenatal Antibiotic Exposure on the Development
of AD in Infancy
Table 2 and table S1 show how the development of AD in
infancy related to cesarean section birth and/or prenatal antibiotic
exposure when there was an allergic genetic background (defined
as one or both parents having a history of allergic disease). In
multivariable regression analyses, cesarean section significantly
increased the odds of AD in infants when there was a history of
parental allergic diseases (aOR 3.46, 95% CI 1.43–8.39, p,0.01,
Table 2). Also, cesarean section significantly increased the odds of
AD in infants than vaginal delivery in subjects with parental
allergic history (aOR 2.83, 95% CI 1.03–7.73, p-value = 0.04, data
not shown).
However, prenatal antibiotic exposure did not significantly
elevate the odds of AD in infants when there was a parental
allergic disease history (Table S1).
When the three factors (parental allergic disease history,
cesarean delivery, and prenatal antibiotic exposure) were each
defined as risk factor of AD in infancy, multivariable regression
analysis revealed that the more risk factors there were, the higher
the likelihood that the infant would be diagnosed with AD at the
age of 1 year (aOR 10.62, 95% CI 1.28–88.37, p = 0.03; Table 3).
Additive Effects between Cesarean Delivery or Prenatal
Antibiotic Exposure and IL-13 or CD14 Gene
Polymorphisms on Infant AD Risk
The distributions of two polymorphisms of the IL-13 and CD14
were in Hardy–Weinberg equilibrium. The genetic polymor-
phisms IL-13 rs20541 and CD14 rs2569190 themselves did not
significantly influence the risk of AD in infancy (data not shown).
However, compared to vaginally delivered infants with the IL-13
rs20541 GG genotype, vaginally delivered infants with the IL-13
rs20541 GA+AA genotypes tended to have a higher risk of infant
AD (aOR 2.37, 95% CIs 0.96–5.84; p = 0.06; Table 4). The
Table 1. Characteristics of the participating infants.
Individual characteristics Number (n/d)* Percentage (%) or mean 6 SD
Male gender 229/412 55.6
Gestational age at birth, weeks 39.261.2
Maternal education level
Low 300/393 76.3
High{ 93/393 23.7
Mother’s age at delivery, years 32.363.5
Pre-pregnancy maternal body-mass index 20.862.7
Prenatal smoking
No 150/384 39.1
Passive 234/384 60.9
Prenatal exposure to pets 11/381 2.9
Prenatal exposure to antibiotics 38/384 9.9
Mode of delivery
Vaginal 210/311 67.5
Cesarean section 101/311 32.5
History of parental allergic diseases 178/373 47.7
Older sibling(s) 138/390 35.4
Atopic dermatitis ever 116/412 28.2
*n, number of children with each characteristic; d, the total number of children with information available on this characteristic.
{graduated from graduate school.
doi:10.1371/journal.pone.0096603.t001
Table 2. Combined effects of mode of delivery and parental history of allergic diseases on the development of atopic dermatitis
(AD) at 1 year of age.
Parental history of allergic diseases/Delivery mode Number (%) of AD OR (95% CI) p-value aOR (95% CI)* p-value
Negative parental history/Vaginal delivery 25 (23.6) 1.00 1.00
Negative parental history/C-section delivery 12 (24.5) 1.21 (0.59–2.50) 0.60 1.40 (0.57–3.47) 0.47
Positive parental history/Vaginal delivery 25 (30.9) 2.14 (1.19–3.83) 0.01 1.44 (0.69–3.01) 0.33
Positive parental history/C-section delivery 23 (48.9) 2.69 (1.36–5.29) ,0.01 3.46 (1.43–8.39) ,0.01
*Adjusted for gestational age at birth, sex, pre-pregnancy maternal body-mass index, maternal age at delivery, maternal education level, prenatal exposure to smoke,
prenatal exposure to pets, and presence of older sibling(s).
doi:10.1371/journal.pone.0096603.t002
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infants who had the GG genotype had a significantly higher risk of
AD if they were delivered by cesarean section (aOR 3.85, 95% CI
1.25–11.83, p = 0.02). This effect of cesarean section was even
more pronounced in infants who had the GA+AA genotypes (aOR
4.70, 95% CIs 1.43–15.40; p = 0.01).
With regard to the CD14 genotypes, compared to vaginally
delivered infants with the CD14 rs2569190 TT genotype, infants
with the TT genotype who were born by cesarean section tended
to have a higher risk of AD (aOR 3.11, 95% CIs 0.80–12.12,
p = 0.10). This effect of cesarean section became significant in
infants who had the CD14 rs2569190 TC+CC genotypes (aOR
3.56, 95% CI 1.12–11.36, p = 0.03; Table 3). Combined effect
between CD14 rs2569190 and delivery mode has a significant
trend P-value (P = 0.02).
With regard to prenatal antibiotic exposure, multivariable
regression analysis revealed that there was a statistically significant
trend for an association between this factor and IL-13 rs20541
genotype (trend p-value,0.05, data not shown). This trend was
not observed for the CD14 rs2569190 genotype.
Additive Effects between Unfavorable Genotypes and
One or Two Environmental Risk Factors on the
Development of AD in Infancy
The subjects were divided into four groups according to the
number of risk factors, namely the presence of unfavorable IL-13
rs20541 or CD14 rs2569190 genotypes, prenatal antibiotic
exposure, and cesarean delivery. The risk of AD in each group
was then assessed relative to the group who had none of the three
risk factors (Fig. 1 and Table S2). In terms of the IL-13 rs20541
genotype, the aOR for AD rose as the number of risk factors
increased (one risk factor: aOR 2.59, 95% CIs 1.04–6.45; two risk
factors: aOR 5.09, 95% CIs 1.57–16.52; three risk factors: aOR
9.56, 95% CIs 0.81–112.97; trend p-value,0.01). Although the
statistical power to conduct analyses with the CD14 rs2569190
genotype was limited, the AD risk also rose as the number of risk
factors increased (trend p-value 0.03, Table S2). Thus, unfavorable
genotypes and exposure to prenatal environmental risk factors
appeared act addictively in increasing AD risk in infancy.
Discussion
This prospective birth cohort study showed for the first time that
the impact of important intestinal microbiota-shaping risk factors
(the delivery mode and prenatal antibiotic exposure) on the early
development of AD can be modified by the genetic background
(functional IL-13 and CD14 gene variants) in a additive fashion.
The present study also showed that cesarean delivery and prenatal
antibiotic exposure may affect the gut microbiota diversity in
infants.
Although cesarean section and prenatal antibiotic exposure did
not associate independently with an increased AD risk in infancy,
infants who were delivered by cesarean section and had been
exposed prenatally to antibiotics were more likely to have AD than
Table 3. Additive effects of mode of delivery, prenatal antibiotic exposure, and parental history of allergic diseases on the
development of atopic dermatitis (AD) at 1 year of age.
Number of risk factors{ Number (%) of AD OR (95% CI) p-value aOR (95% CI)* p-value
Risk (0) 20 (21.3) 1.00 1.00
Risk (1) 35 (28.9) 1.51 (0.80–2.83) 0.20 1.83 (0.89–3.73) 0.10
Risk (2) 22 (42.3) 2.71 (1.30–5.68) 0.01 3.10 (1.28–7.51) 0.01
Risk (3) 5 (62.5) 6.17 (1.36–28.03) 0.02 10.62 (1.28–88.37) 0.03
Trend P-value 0.001 0.001
*Adjusted for gestational age at birth, sex, pre-pregnancy maternal body-mass index, maternal age at delivery, maternal education level, prenatal exposure to smoke,
prenatal exposure to pets, and presence of older sibling(s).
{Risk factors were: parental history of allergic diseases, prenatal use of antibiotics, and cesarean delivery.
doi:10.1371/journal.pone.0096603.t003
Table 4. Combined effects of IL-13 or CD14 genetic variations and delivery mode on the development of atopic dermatitis (AD) at
1 year of age.
IL-13 rs20541/Delivery mode Number (%) of AD OR (95% CI) p-value aOR (95% CI)* p-value
GG/Vaginal delivery 17 (22.7) 1.00 1.00
GA+AA/Vaginal delivery 27 (26.7) 1.24 (0.61–2.54) 0.55 2.37 (0.96–5.84) 0.06
GG/C-section delivery 15 (45.5) 2.84 (1.19–6.81) 0.02 3.85 (1.25–11.83) 0.02
GA+AA/C-section delivery 13 (43.3) 2.61 (1.06–6.43) 0.04 4.70 (1.43–15.40) 0.01
CD14 rs2569190/Delivery mode
TT/Vaginal delivery 13 (23.6) 1.00 1.00
TC+CC/Vaginal delivery 28 (26.7) 1.18 (0.55–2.51) 0.68 1.34 (0.53–3.44) 0.54
TT/C-section delivery 9 (42.9) 2.42 (0.84–7.03) 0.10 3.11 (0.80–12.12) 0.10
TC+CC/C-section delivery 17 (43.6) 2.50 (1.03–6.06) 0.04 3.56 (1.12–11.36) 0.03
*Adjusted for gestational age at birth, sex, pre-pregnancy maternal body-mass index, maternal age at delivery, maternal education level, prenatal exposure to smoke,
prenatal exposure to pets, presence of older sibling(s), and parental history of allergic diseases.
doi:10.1371/journal.pone.0096603.t004
Gene & Environmental Factors Had a Additive Effect on AD
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those who were born vaginally and had not had prenatal antibiotic
exposure. This trend was particularly notable in infants who
carried risk-associated genotypes or whose parents had an allergic
disease history. The present study confirms that the influence of
cesarean section and prenatal antibiotic exposure on the
development of AD should be assessed in the context of individual
genetic susceptibility (e.g., parental allergic disease history).
Another study reported a similar observation: Norwegian children
who were born by cesarean section and had a maternal history of
allergy had a 9-fold higher likelihood of food allergy than those
who were born by vaginal delivery and had no maternal history of
allergy [18].
In early life, the intestinal microbial composition changes
markedly. A previous study showed that the mode of delivery
significantly influences the microbiota composition of the intestine
of neonates [19]. Interestingly, previous studies have also shown
that the intestinal microbiota of cesarean section-born infants is
similar to the microbiota of infants born to mothers who received
antibiotics during late pregnancy and/or while breastfeeding
[20,21]. Other studies also reported that in cesarean delivered
Figure 1. Additive effects of unfavorable IL-13 or CD14 genotypes, prenatal antibiotic exposure, and delivery mode on the
development of atopic dermatitis in infancy. (A) IL-13 rs20541 genotype. (B) CD14 rs2569190 genotype. aOR, odds ratio adjusted for
gestational age at birth, sex, pre-pregnancy maternal body-mass index, maternal age at delivery, maternal education level, prenatal exposure to
smoke, prenatal exposure to pets, presence of older sibling(s), and parental history of allergic diseases.
doi:10.1371/journal.pone.0096603.g001
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infants, there was a delay in fecal colonization and low numbers of
Bacteroides fragilis [22,23]. Moreover, in the first year of life, infants
delivered by cesarean section do not catch up to vaginally
delivered infants in terms of colonization by Bacteroides and
Escherichia coli [24]. Hence, cesarean section and prenatal antibiotic
exposure may promote the suboptimal development of the
microbiota in infancy to similar extents. The present study showed
that infants who had been exposed to antibiotics prenatally and
were born by cesarean delivery had lower total microbiota
diversity in the stool at 6 month of age than infants who did not
have prenatal exposure to antibiotics and were born by vaginal
delivery. The two groups did not differ significantly in terms of any
of the dominant bacterial genera probably because of the small
sample size. Thus, the findings of the present study support the
notion that prenatal antibiotic exposure and delivery mode may
affect the gut microbiota.
Although the gut microbiota is believed to play an intermediate
role in the causal pathway between mode of delivery and AD, only
one study has assessed this role directly [25]. That study showed
that mode and place of delivery affect the gut microbiota at 1
month of age, especially in terms of Clostridium difficile colonization,
and that this subsequently influences the risk of atopic manifes-
tations at the age of 6–7 years. That study also showed that gut
microbiota composition and mode and place of delivery both
mainly associated with the development of allergic diseases in
children with a positive family history of atopy. The present study
demonstrated for the first time that not only cesarean delivery but
also prenatal exposure to antibiotics play an important role in the
development of AD in infancy, particularly in infants carrying IL-
13 and CD14 genetic susceptibility alleles.
The present study showed that while cesarean section itself may
influence the development of AD in infancy, this effect was
enhanced in infants carrying the IL-13 rs20541 GA+AA
genotypes. IL-13 rs20541 is a single nucleotide polymorphism
(SNP) in the coding region of the IL-13 gene. In our previous
study, children with the IL-13 GA+AA polymorphisms were found
to be at increased risk of allergic rhinitis if they were exposed to
mold in the home during their first year of life [26], and were
associated with susceptibility of asthma [27]. For this reason, and
because the combined effects between cesarean section or prenatal
antibiotic exposure and IL-13 SNPs had not yet been examined,
the IL-13 rs20541 SNP was selected for our study.
The present study also supports the notion that the C allele of
the CD14 SNP rs2569190 confers a risk of AD in infants who are
born by cesarean section. In rodents, oral exposure to lipopoly-
saccharides during vaginal birth activates gut epithelial cells [28].
By contrast, gut epithelial activation is not found in mice born by
cesarean section. The Allergy and Endotoxin (ALEX) Study [29]
supported the endotoxin switch theory that the C allele of CD14
rs2569190 confers risk at low endotoxin exposure whereas the T
allele confers risk at high endotoxin exposure. Thus, infants with
the C allele of CD14 SNP rs2569190 may be at higher risk of AD
if their endotoxin exposure is low because their microbiota is
undeveloped due to cesarean delivery and prenatal antibiotic
exposure.
The strengths of the present study include its prospective nature
and its population-based design. This is the first study to assess
how cesarean section, prenatal antibiotic exposure, and gene
susceptibility alleles interact in the development of AD in infancy
while adjusting for other prenatal environment factors. We
acknowledge that it also has some limitations. The main
limitations are the relatively smaller sample size compared to
those in similar studies. Our findings should be confirmed by
larger studies. In addition, this study focused on only two well-
known candidate genes that are involved in Th1/Th2 balance. It
remains likely that other, as-yet unknown but important, genes can
also regulate the influence of cesarean section and prenatal
antibiotic exposure on the development of AD in infancy.
However, IL-13 and CD14 genes are good candidate genes in
terms of allergic susceptibility and innate immunity since several
studies have shown that IL-13 rs1295685 and CD14 rs20541 play
an important role in the development of allergic diseases in
Korean children [26,27,30]. Another possible limitation is that the
diet history of the infants in this study was not considered. As a
result, the present study focused largely on the prenatal
environmental factors that may influence the development of
AD in infancy. We showed the limited results of difference of gut
microbiota in small population because it is very difficult to find
the pregnant women who had used antibiotics during pregnancy.
Conclusions
We found that cesarean section, prenatal antibiotic exposure,
and unfavorable risk alleles acted additively to promote the
development of AD in infancy. The present findings suggest that
further studies that evaluate the effect of gut microbiota on AD in
the context of individual genetic variation are warranted. The type
of information yielded by such studies might enable physicians in
the future to provide more personalized medical care and advice
to mothers that will reduce the risk of AD in their children.
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